Edition:
United States

Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

Imprimis Pharmaceuticals Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

24 Sep 2016 Reuters Investment Profile 12 $20.00

ValuEngine Rating and Forecast Report for IMMY

Advanced academic research that brings you superior investment strategies in an actionable format. The most comprehensive and...

25 Sep 2016 ValuEngine, Inc. 11 $25.00

IMPRIMIS PHARMACEUTICALS INC (IMMY=US) - SHORT AND LONG TERM FORECASTS FOR ACTIVE TRADERS

"www.pechala.com, the world's largest market forecasting firm with subscribers in 83 different countries provide forecasts of...

24 Sep 2016 Pechala's Reports 2 $25.00

Value Graph: IMPRIMIS PHARMA -- IMMY

23 Sep 2016 Ford Investor Services, Inc. 1 $12.00

Imprimis Pharmaceuticals, Inc. (IMMY) - Financial and Strategic SWOT Analysis Review

Imprimis Pharmaceuticals, Inc. (IMMY) - Financial and Strategic SWOT Analysis Review Summary Imprimis Pharmaceuticals, Inc. (...

19 Sep 2016 GlobalData 77 $300.00

Wright Investors Service Comprehensive Report for Imprimis Pharmaceuticals Incorporated

Quantitative analyses of financial statements (Income Statement, Balance Sheet and Sources of Capital), extensive ratio table...

16 Sep 2016 Wright Reports 65 $75.00

Thomson Reuters Stock Report - Imprimis Pharmaceuticals Inc (IMMY-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

05 Aug 2016 Thomson Reuters Stock Report 12 $25.00

Imprimis Pharmaceuticals, Inc. (IMMY) - Financial and Strategic SWOT Analysis Review

Imprimis Pharmaceuticals, Inc. (IMMY) - Financial and Strategic SWOT Analysis Review Summary Imprimis Pharmaceuticals, Inc. (...

03 Jun 2016 GlobalData 76 $300.00

Thomson Reuters Stock Report - Imprimis Pharmaceuticals Inc (IMMY-O)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

10 May 2016 Thomson Reuters Stock Report 12 $25.00

IMMY.OQ - Event Transcript of Imprimis Pharmaceuticals Inc conference call, Mar. 23, 2016 / 4:30PM ET

Edited Event Transcript of IMMY.OQ conference call, Mar. 23, 2016 / 4:30PM ET Boston, Apr 12, 2016 (Thomson StreetEvent...

23 Mar 2016 Thomson Reuters StreetEvents 9 $75.00